Creo Medical posts 40% revenue growth, narrows losses in H1 2025
Revenue for the six months ended June 30 rose to £2.2 million from £1.6 million a year earlier LONDON: Creo Medical Group plc (AIM: CREO), a UK-based medical device company specializing in minimally invasive surgical endoscopy, reported a 40% rise…